Mostra i principali dati dell'item
| dc.contributor.author | Perez, MJ | |
| dc.contributor.author | Gonzalez-Sanchez, E | |
| dc.contributor.author | Gonzalez-Loyola, A | |
| dc.contributor.author | González de Buitrago Arriero, José Manuel | |
| dc.contributor.author | García Marín, José Juan | |
| dc.date.accessioned | 2025-01-27T15:35:20Z | |
| dc.date.available | 2025-01-27T15:35:20Z | |
| dc.date.issued | 2011 | |
| dc.identifier.citation | Perez, M. J., Gonzalez‐Sanchez, E., Gonzalez‐Loyola, A., Gonzalez‐Buitrago, J. M., & Marin, J. J. G. (2011). Mitochondrial genome depletion dysregulates bile acid‐and paracetamol‐induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells. British journal of pharmacology, 162(8), 1686-1699. | es_ES |
| dc.identifier.issn | 0007-1188 | |
| dc.identifier.uri | http://hdl.handle.net/10366/162980 | |
| dc.description.abstract | [EN] BACKGROUND AND PURPOSE Mitochondria are involved in the toxicity of several compounds, retro-control of gene expression and apoptosis activation. The effect of mitochondrial genome (mtDNA) depletion on changes in ABC transporter protein expression in response to bile acids and paracetamol was investigated. EXPERIMENTAL APPROACH Hepa 1-6 mouse hepatoma cells with 70% decrease in 16S/18S rRNA ratio (Rho cells) were obtained by long-term treatment with ethidium bromide. KEY RESULTS Spontaneous apoptosis and reactive oxygen species (ROS) generation were decreased in Rho cells. Following glycochenodeoxycholic acid (GCDCA) or paracetamol, Rho cells generated less ROS and were more resistant to cell death. Apoptosis induced by GCDCA and Fas was also reduced. The basal expression of Mdr1 was significantly enhanced, but this was not further stimulated by GCDCA or paracetamol, as observed in wild-type (WT) cells. Basal expression of Mrp1 and Mrp4 was similar in WT and Rho cells, whereas they were up-regulated only in WT cells after GCDCA or paracetamol, along with the transcription factors Shp and Nrf2, but not Fxr or Pxr. Increased expression of Nrf2 was accompanied by its enhanced nuclear translocation. Glycoursodeoxycholic acid failed to cause any of the effects observed for GCDCA or paracetamol. CONCLUSIONS AND IMPLICATIONS The Nrf2-mediated pathway is partly independent of ROS production. Nuclear translocation of Nrf2 is insufficient to up-regulate Mdr1, Mrp1 and Mrp4, which requires the participation of other regulatory element(s) whose activation | es_ES |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Wiley. British Pharmacological Society | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | ABC proteins; | es_ES |
| dc.subject | paracetamol | es_ES |
| dc.subject | bile acid | es_ES |
| dc.subject | cholestasis | es_ES |
| dc.subject | drug toxicity | es_ES |
| dc.subject | liver | es_ES |
| dc.subject | mitochondria | es_ES |
| dc.subject | multidrug resistance | es_ES |
| dc.subject | retrograde control | es_ES |
| dc.subject | rho cells | es_ES |
| dc.subject.mesh | DNA, Mitochondrial | * |
| dc.subject.mesh | Acetaminophen | * |
| dc.subject.mesh | Cholestasis | * |
| dc.title | Mitochondrial genome depletion dysregulates bile acid‐ and paracetamol‐induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1111/j.1476-5381.2010.01174.x | es_ES |
| dc.subject.unesco | 3209 Farmacología | es_ES |
| dc.identifier.doi | 10.1111/j.1476-5381.2010.01174.x | |
| dc.relation.projectID | Carlos III, FIS CP05/0135 | es_ES |
| dc.relation.projectID | Carlos III, FIS PI070517 | es_ES |
| dc.relation.projectID | Carlos III, FIS PI080151 | es_ES |
| dc.relation.projectID | Junta de Castilla y Leon GR75-2008 | es_ES |
| dc.relation.projectID | Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and the European Regional Development Fund (ERDF) BFU2006-12577 | es_ES |
| dc.relation.projectID | Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and the European Regional Development Fund (ERDF) SAF2009-08493 | es_ES |
| dc.relation.projectID | Fundación Investigación Médica Mutua Madrileña Conv-VI, 2009 | es_ES |
| dc.relation.projectID | Ester González-Sánchez is a recipient of a predoctoral fellowship from the Ministerio de Educación, Spain (Grant AP2008-03762). | es_ES |
| dc.rights.accessRights | info:eu-repo/semantics/closedAccess | es_ES |
| dc.identifier.pmid | 21175587 | |
| dc.identifier.essn | 1476-5381 | |
| dc.journal.title | British Journal of Pharmacology | es_ES |
| dc.volume.number | 162 | es_ES |
| dc.issue.number | 8 | es_ES |
| dc.page.initial | 1686 | es_ES |
| dc.page.final | 1699 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | colestasis | * |
| dc.subject.decs | ADN mitocondrial | * |
| dc.subject.decs | acetaminofén | * |









